<code id='0B97D35CFB'></code><style id='0B97D35CFB'></style>
    • <acronym id='0B97D35CFB'></acronym>
      <center id='0B97D35CFB'><center id='0B97D35CFB'><tfoot id='0B97D35CFB'></tfoot></center><abbr id='0B97D35CFB'><dir id='0B97D35CFB'><tfoot id='0B97D35CFB'></tfoot><noframes id='0B97D35CFB'>

    • <optgroup id='0B97D35CFB'><strike id='0B97D35CFB'><sup id='0B97D35CFB'></sup></strike><code id='0B97D35CFB'></code></optgroup>
        1. <b id='0B97D35CFB'><label id='0B97D35CFB'><select id='0B97D35CFB'><dt id='0B97D35CFB'><span id='0B97D35CFB'></span></dt></select></label></b><u id='0B97D35CFB'></u>
          <i id='0B97D35CFB'><strike id='0B97D35CFB'><tt id='0B97D35CFB'><pre id='0B97D35CFB'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:hotspot    Page View:351
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In